• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国不同性别维吾尔族成年人血脂异常患病率的趋势:一项回顾性队列研究。

Trends in dyslipidemia prevalence among Uyghur adults of different genders in China: a retrospective cohort study.

作者信息

Maimaitituersun Gulinigaer, Jureti Subinuer, Yi Ziyu, Zhou Yaqi, Li Meng, Wei Mengwei, Liu Ziyang, Jin Menglong, Fu Zhenyan

机构信息

The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang, China.

Xinjiang Medical University, Wulumuqi, China.

出版信息

PeerJ. 2025 May 2;13:e19344. doi: 10.7717/peerj.19344. eCollection 2025.

DOI:10.7717/peerj.19344
PMID:40330697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12051936/
Abstract

BACKGROUND

To analyze the prevalence and epidemiological characteristics of dyslipidemia among adults of different genders in Xinjiang, China, providing a basis for promoting ideal lipid management among the Uyghur population.

METHODS

In this retrospective study, we included 7,646 Uyghur adults from the 2021 physical examination data in Hotan, Xinjiang, and followed up with all participants in 2023 for analysis. Participants completed lifestyle and medical history questionnaires and underwent lipid profiling. Dyslipidemia was defined according to the 2023 Chinese guidelines for lipid management. Group differences were analyzed using -tests, ANOVA, and chi-square tests, the trend test for ordered categorical variables was conducted using univariate linear regression, and multivariable logistic regression was performed to explore risk factors for dyslipidemia.

RESULTS

In 2023, the average levels of waist circumference, fasting glucose, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and non-HDL-C among Uyghur men and women, as well as the prevalence of diabetes, increased compared to 2021, with significant statistical differences within the same gender groups ( < 0.001). The primary types of dyslipidemia among Uyghur adults were low HDL-C. After age and gender standardization, the overall standardized prevalence of high low-density lipoprotein cholesterol (LDL-C), hypertriglyceridemia, and low HDL-C showed a downward trend, with a more pronounced decrease among men. The prevalence of hypercholesterolemia and high non-HDL-C increased from 2021, with a greater increase among women. In 2023, the standardized prevalence rates of hypercholesterolemia, high LDL-C, low HDL-C, hypertriglyceridemia, and high non-HDL-C were higher in women than in men. Multivariable logistic regression adjusted for multiple factors indicated that higher educational attainment (OR 1.992; 95% CI [1.042-3.808];  = 0.037), overweight (OR 1.303; 95% CI [1.085-1.566];  = 0.005), obesity (OR 1.520; 95% CI [1.226-1.886];  = 0.000), and central obesity (OR 1.013; 95% CI [1.006-1.021];  = 0.001) were associated with dyslipidemia in Uyghur men, while in Uyghur women, dyslipidemia prevalence was mainly related to obesity (OR 1.549; 95% CI [1.261-1.902];  = 0.000) and central obesity (OR 1.009; 95% CI [1.002-1.016];  = 0.01).

CONCLUSION

The primary forms of dyslipidemia among Uyghur adults include low HDL-C levels. The prevalence of high LDL-C, hypertriglyceridemia, and low HDL-C is showing a declining trend, particularly among men. In contrast, the prevalence of hypercholesterolemia and high non-HDL-C is increasing more significantly among women. In men, risk factors for dyslipidemia include higher educational attainment, being overweight, obesity, and central obesity. In women, the prevalence of dyslipidemia is mainly associated with obesity and central obesity.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/12051936/4cc3f8814469/peerj-13-19344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/12051936/4464abf9da70/peerj-13-19344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/12051936/4cc3f8814469/peerj-13-19344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/12051936/4464abf9da70/peerj-13-19344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d659/12051936/4cc3f8814469/peerj-13-19344-g002.jpg
摘要

背景

分析中国新疆不同性别成年人血脂异常的患病率及流行病学特征,为促进维吾尔族人群理想的血脂管理提供依据。

方法

在这项回顾性研究中,我们纳入了来自新疆和田2021年体检数据中的7646名维吾尔族成年人,并于2023年对所有参与者进行随访分析。参与者完成了生活方式和病史问卷,并接受了血脂检测。血脂异常根据2023年中国血脂管理指南进行定义。采用t检验、方差分析和卡方检验分析组间差异,使用单变量线性回归对有序分类变量进行趋势检验,并进行多变量逻辑回归以探索血脂异常的危险因素。

结果

2023年,维吾尔族男性和女性的腰围、空腹血糖、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)和非HDL-C的平均水平以及糖尿病患病率与2021年相比有所增加,同性别组内存在显著统计学差异(P<0.001)。维吾尔族成年人血脂异常的主要类型为HDL-C降低。经过年龄和性别标准化后,高低密度脂蛋白胆固醇(LDL-C)、高甘油三酯血症和低HDL-C的总体标准化患病率呈下降趋势,男性下降更为明显。高胆固醇血症和高非HDL-C的患病率自2021年起上升,女性上升幅度更大。2023年,女性高胆固醇血症、高LDL-C、低HDL-C、高甘油三酯血症和高非HDL-C的标准化患病率高于男性。多因素调整后的多变量逻辑回归表明,较高的教育程度(OR 1.992;95%CI[1.042 - 3.808];P = 0.037)、超重(OR 1.303;95%CI[1.085 - 1.566];P = 0.005)、肥胖(OR 1.520;95%CI[1.226 - 1.886];P = 0.000)和中心性肥胖(OR 1.013;95%CI[1.006 - 1.021];P = 0.001)与维吾尔族男性血脂异常相关,而在维吾尔族女性中,血脂异常患病率主要与肥胖(OR 1.549;95%CI[1.261 - 1.902];P = 0.000)和中心性肥胖(OR 1.009;95%CI[1.002 - 1.016];P = 0.01)有关。

结论

维吾尔族成年人血脂异常的主要形式包括HDL-C水平降低。高LDL-C、高甘油三酯血症和低HDL-C的患病率呈下降趋势,尤其是男性。相比之下,高胆固醇血症和高非HDL-C的患病率在女性中上升更为显著。在男性中,血脂异常的危险因素包括较高的教育程度、超重、肥胖和中心性肥胖。在女性中,血脂异常患病率主要与肥胖和中心性肥胖有关。

相似文献

1
Trends in dyslipidemia prevalence among Uyghur adults of different genders in China: a retrospective cohort study.中国不同性别维吾尔族成年人血脂异常患病率的趋势:一项回顾性队列研究。
PeerJ. 2025 May 2;13:e19344. doi: 10.7717/peerj.19344. eCollection 2025.
2
[Epidemiological characteristics of dyslipidemia in remote rural areas of Xinjiang, 2009-2010].[2009 - 2010年新疆偏远农村地区血脂异常的流行病学特征]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Nov 6;50(11):996-1000. doi: 10.3760/cma.j.issn.0253-9624.2016.11.014.
3
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.土耳其成年人血脂异常及相关危险因素的患病率:特拉布宗血脂研究
Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.
4
Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP).中国农村和城市成年人血脂异常的患病率及相关危险因素:来自中国国家卒中筛查与防治项目(CNSSPP)的结果。
BMC Public Health. 2019 Nov 11;19(1):1500. doi: 10.1186/s12889-019-7827-5.
5
[Epidemic features of dyslipidemia among Uygur, Kazakh, and Han adults in Xinjiang, China in 2010].[2010年中国新疆维吾尔族、哈萨克族和汉族成年人血脂异常流行特征]
Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Oct;47(10):949-53.
6
[Prevalence and risk factors of dyslipidemia in a rural population of Henan Province, China].[中国河南省农村人群血脂异常的患病率及危险因素]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Sep 6;50(9):799-805. doi: 10.3760/cma.j.issn.0253-9624.2016.09.010.
7
[Prevalence of dyslipidemia and normal blood lipids level in Uygur population in Kashgar area of Xinjiang Uygur Autonomous Region].[新疆维吾尔自治区喀什地区维吾尔族人群血脂异常及血脂正常水平的患病率]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jun 10;38(6):702-708. doi: 10.3760/cma.j.issn.0254-6450.2017.06.003.
8
[Prevalence trends and related factors of hypertension patients complicating with dyslipidemia in community of Guandong province between 2013 and 2018].2013年至2018年广东省社区高血压合并血脂异常患者的患病率趋势及相关因素
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Oct 24;49(10):986-992. doi: 10.3760/cma.j.cn112148-20210311-00214.
9
Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.中国农村人群血脂异常的流行率、知晓率、治疗率、控制率及其危险因素:河南农村队列研究。
Lipids Health Dis. 2018 May 22;17(1):119. doi: 10.1186/s12944-018-0768-7.
10
The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China.中国西北部农村人群中低高密度脂蛋白胆固醇水平和血脂异常的高患病率。
PLoS One. 2015 Dec 7;10(12):e0144104. doi: 10.1371/journal.pone.0144104. eCollection 2015.

本文引用的文献

1
U-shaped association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality risk in obese adults: evidence from NHANES 1999-2018.肥胖成年人中非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与死亡风险之间的U型关联:来自1999 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Front Cardiovasc Med. 2025 Jan 10;11:1524465. doi: 10.3389/fcvm.2024.1524465. eCollection 2024.
2
The predictive value of triglyceride-glucose index combined with non-high-density lipoprotein cholesterol in coronary heart disease.甘油三酯-葡萄糖指数联合非高密度脂蛋白胆固醇在冠心病中的预测价值
BMC Cardiovasc Disord. 2025 Jan 9;25(1):10. doi: 10.1186/s12872-024-04410-z.
3
Dyslipidemia and the Current State of Cardiovascular Disease: Epidemiology, Risk Factors, and Effect of Lipid Lowering.
血脂异常与心血管疾病现状:流行病学、危险因素及降脂治疗的影响。
Can J Cardiol. 2024 Aug;40(8S):S4-S12. doi: 10.1016/j.cjca.2024.04.017.
4
Real-world evidence evaluation of LDL-C in hospitalized patients: a population-based observational study in the timeframe 2021-2022.基于真实世界证据的住院患者 LDL-C 评估:2021-2022 年期间的一项基于人群的观察性研究。
Lipids Health Dis. 2024 Jul 24;23(1):224. doi: 10.1186/s12944-024-02221-x.
5
Subclinical Atherosclerosis to Guide Treatment in Dyslipidemia and Diabetes Mellitus.亚临床动脉粥样硬化指导血脂异常和糖尿病患者的治疗。
Curr Atheroscler Rep. 2024 Jun;26(6):217-230. doi: 10.1007/s11883-024-01202-w. Epub 2024 Apr 25.
6
Nonlinear relationship between high-density lipoprotein cholesterol and cardiovascular disease: an observational and Mendelian randomization analysis.高密度脂蛋白胆固醇与心血管疾病之间的非线性关系:观察性和孟德尔随机化分析。
Metabolism. 2024 May;154:155817. doi: 10.1016/j.metabol.2024.155817. Epub 2024 Feb 15.
7
Novel Pharmacotherapies for Hyperlipidemia.新型高血脂症药物治疗
Prim Care. 2024 Mar;51(1):27-40. doi: 10.1016/j.pop.2023.08.002. Epub 2023 Sep 1.
8
Advances in Treatment of Dyslipidemia.血脂异常治疗进展。
Int J Mol Sci. 2023 Aug 27;24(17):13288. doi: 10.3390/ijms241713288.
9
Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives.心肌缺血再灌注损伤治疗的性别差异:从基础科学到临床观点。
Cells. 2023 Aug 16;12(16):2077. doi: 10.3390/cells12162077.
10
Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study.富含甘油三酯的脂蛋白残粒、低密度脂蛋白与冠心病风险:英国生物库研究。
Eur Heart J. 2023 Oct 14;44(39):4186-4195. doi: 10.1093/eurheartj/ehad337.